Company profile
OnconiX AG
Empowering oncologists with personalized cancer drug testing to help identify the best therapy for every patient.
- Industry
- Biotechnology Research
- Employees
- 6
- Headquarters
- Bern, Bern
- Founded
- 2025
- LinkedIn followers
- 824
- Office locations
- 1
OnconiX AG company summary
OnconiX AG is a company in the Biotechnology Research industry, headquartered in Bern, Bern, founded in 2025. On LinkedIn the company has around 6 employees and 824 followers.
What technology does OnconiX AG use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About OnconiX AG
OnconiX is predicting which cancer therapy works, before treatment begins. Every tumor is different. Every patient is different. Yet cancer therapies are still chosen mainly from histology, genetics, and population statistics: tools that tell oncologists what tends to work across many patients, but not how one specific tumor will actually respond. Too often, the result is trial and error: ineffective treatments, avoidable side effects, rising costs, and time that cancer patients simply do not have. Treatment decisions should be based on a patient's own tumor, not on averages. With our functional testing service OncoXpress, we grow living, three-dimensional replicas of a patient's own tumor, known as patient-derived organoids, or patient tumor avatars. We test real cancer drugs directly on them, generating functional drug-response data helping oncologists replace guesswork with evidence. Built on over a decade of translational research at the University of Bern, our platform is currently being validated across prospective clinical trials with leading hospital partners. But the real engine is our team. OnconiX brings together experienced entrepreneurs, business experts, and translational scientists, together with leading clinicians and professors in oncology and tumor biology. We are united by one goal: making personalized cancer care accessible to every patient. Today, OncoXpress is available as a research-use-only service. Our next step is clinical certification, bringing this technology into everyday cancer therapy. Stay connected and visit onconix.com to follow our journey.
Where is OnconiX AG located?
OnconiX AG lists 1 location.
Compare companies similar to OnconiX AG
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
OnconiX AG onconix.com | Biotechnology Research | 6 | 2025 | Bern, Bern |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about OnconiX AG
What does OnconiX AG do?
OnconiX is predicting which cancer therapy works, before treatment begins. Every tumor is different. Every patient is different. Yet cancer therapies are still chosen mainly from histology, genetics, and population statistics: tools that tell oncologists what tends to work across many patients, but not how one specific tumor will actually respond. Too often, the result is trial and error: ineffective treatments, avoidable side effects, rising costs, and time that cancer patients simply do not have. Treatment decisions should be based on a patient's own tumor, not on averages. With our functional testing service OncoXpress, we grow living, three-dimensional replicas of a patient's own tumor, known as patient-derived organoids, or patient tumor avatars. We test real cancer drugs directly on them, generating functional drug-response data helping oncologists replace guesswork with evidence. Built on over a decade of translational research at the University of Bern, our platform is currently being validated across prospective clinical trials with leading hospital partners. But the real engine is our team. OnconiX brings together experienced entrepreneurs, business experts, and translational scientists, together with leading clinicians and professors in oncology and tumor biology. We are united by one goal: making personalized cancer care accessible to every patient. Today, OncoXpress is available as a research-use-only service. Our next step is clinical certification, bringing this technology into everyday cancer therapy. Stay connected and visit onconix.com to follow our journey.
How many employees does OnconiX AG have?
OnconiX AG has around 6 employees on LinkedIn.
Where is OnconiX AG headquartered?
OnconiX AG is headquartered in Bern, Bern.
When was OnconiX AG founded?
OnconiX AG was founded in 2025.
Build a lead list from companies like OnconiX AG
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.